Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1384 | 8143 | 43.7 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GDNF | authKW | 704324 | 5% | 43% | 433 |
2 | GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR | authKW | 522418 | 3% | 53% | 263 |
3 | NEURAL TRANSPLANTATION | authKW | 507212 | 3% | 56% | 241 |
4 | NEURTURIN | authKW | 249734 | 1% | 72% | 92 |
5 | NEUROTROPHIC FACTORS | authKW | 130020 | 3% | 13% | 264 |
6 | PARKINSONS DISEASE | authKW | 125083 | 12% | 3% | 1006 |
7 | NEUROSCIENCES | WoSSC | 121649 | 70% | 1% | 5678 |
8 | GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR GDNF | authKW | 118371 | 1% | 64% | 49 |
9 | BRAIN REPAIR GRP | address | 109312 | 1% | 46% | 63 |
10 | VENTRAL MESENCEPHALON | authKW | 107703 | 1% | 50% | 58 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 121649 | 70% | 1% | 5678 |
2 | Developmental Biology | 9352 | 7% | 0% | 581 |
3 | Cell & Tissue Engineering | 6991 | 3% | 1% | 228 |
4 | Anatomy & Morphology | 1921 | 2% | 0% | 186 |
5 | Clinical Neurology | 1723 | 8% | 0% | 638 |
6 | Transplantation | 1671 | 3% | 0% | 274 |
7 | Medicine, Research & Experimental | 1165 | 6% | 0% | 458 |
8 | Zoology | 915 | 4% | 0% | 355 |
9 | Behavioral Sciences | 243 | 2% | 0% | 139 |
10 | Cell Biology | 213 | 5% | 0% | 393 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRAIN REPAIR GRP | 109312 | 1% | 46% | 63 |
2 | WALLENBERG NEUROSCI | 95048 | 2% | 19% | 135 |
3 | SECT NEURONAL SURVIVAL | 71173 | 0% | 50% | 38 |
4 | NEURAL TRANSPLANTAT | 49602 | 0% | 88% | 15 |
5 | PROGRAM MOL NEUROBIOL | 28892 | 0% | 43% | 18 |
6 | HORMONAL REGULAT | 23787 | 0% | 35% | 18 |
7 | MRC CAMBRIDGE BRAIN REPAIR | 22039 | 0% | 59% | 10 |
8 | SECT TORAT NEUROL | 19008 | 0% | 20% | 26 |
9 | GENES MOTOR SYST | 18128 | 0% | 44% | 11 |
10 | NEUROHISTOL | 17102 | 0% | 35% | 13 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERIMENTAL NEUROLOGY | 102933 | 6% | 5% | 506 |
2 | CELL TRANSPLANTATION | 45980 | 2% | 7% | 181 |
3 | DEVELOPMENTAL BRAIN RESEARCH | 37504 | 3% | 4% | 225 |
4 | JOURNAL OF NEURAL TRANSPLANTATION & PLASTICITY | 36562 | 0% | 41% | 24 |
5 | BRAIN RESEARCH | 33549 | 8% | 1% | 657 |
6 | PROGRESS IN BRAIN RESEARCH | 28038 | 2% | 4% | 181 |
7 | JOURNAL OF COMPARATIVE NEUROLOGY | 25329 | 4% | 2% | 315 |
8 | RESTORATIVE NEUROLOGY AND NEUROSCIENCE | 21781 | 1% | 7% | 82 |
9 | NEUROSCIENCE | 20145 | 4% | 2% | 347 |
10 | NEUROSCIENCE LETTERS | 11229 | 4% | 1% | 311 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GDNF | 704324 | 5% | 43% | 433 | Search GDNF | Search GDNF |
2 | GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR | 522418 | 3% | 53% | 263 | Search GLIAL+CELL+LINE+DERIVED+NEUROTROPHIC+FACTOR | Search GLIAL+CELL+LINE+DERIVED+NEUROTROPHIC+FACTOR |
3 | NEURAL TRANSPLANTATION | 507212 | 3% | 56% | 241 | Search NEURAL+TRANSPLANTATION | Search NEURAL+TRANSPLANTATION |
4 | NEURTURIN | 249734 | 1% | 72% | 92 | Search NEURTURIN | Search NEURTURIN |
5 | NEUROTROPHIC FACTORS | 130020 | 3% | 13% | 264 | Search NEUROTROPHIC+FACTORS | Search NEUROTROPHIC+FACTORS |
6 | PARKINSONS DISEASE | 125083 | 12% | 3% | 1006 | Search PARKINSONS+DISEASE | Search PARKINSONS+DISEASE |
7 | GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR GDNF | 118371 | 1% | 64% | 49 | Search GLIAL+CELL+LINE+DERIVED+NEUROTROPHIC+FACTOR+GDNF | Search GLIAL+CELL+LINE+DERIVED+NEUROTROPHIC+FACTOR+GDNF |
8 | VENTRAL MESENCEPHALON | 107703 | 1% | 50% | 58 | Search VENTRAL+MESENCEPHALON | Search VENTRAL+MESENCEPHALON |
9 | GFR ALPHA 1 | 96897 | 1% | 63% | 41 | Search GFR+ALPHA+1 | Search GFR+ALPHA+1 |
10 | NEURAL GRAFTING | 81922 | 1% | 47% | 47 | Search NEURAL+GRAFTING | Search NEURAL+GRAFTING |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | IBANEZ, CF , ANDRESSOO, JE , (2017) BIOLOGY OF GDNF AND ITS RECEPTORS - RELEVANCE FOR DISORDERS OF THE CENTRAL NERVOUS SYSTEM.NEUROBIOLOGY OF DISEASE. VOL. 97. ISSUE . P. 80 -89 | 91 | 65% | 3 |
2 | KORDOWER, JH , WAKEMAN, DR , DODIYA, HB , (2011) CELL TRANSPLANTATION AND GENE THERAPY IN PARKINSON'S DISEASE.MOUNT SINAI JOURNAL OF MEDICINE. VOL. 78. ISSUE 1. P. 126 -158 | 233 | 55% | 22 |
3 | SULLIVAN, AM , TOULOUSE, A , (2011) NEUROTROPHIC FACTORS FOR THE TREATMENT OF PARKINSON'S DISEASE.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 22. ISSUE 3. P. 157-165 | 128 | 96% | 24 |
4 | KELLY, MJ , O'KEEFFE, GW , SULLIVAN, AM , (2015) VIRAL VECTOR DELIVERY OF NEUROTROPHIC FACTORS FOR PARKINSON'S DISEASE THERAPY.EXPERT REVIEWS IN MOLECULAR MEDICINE. VOL. 17. ISSUE . P. - | 99 | 79% | 3 |
5 | BJORKLUND, A , CENCI, MA , (2010) NEUROTROPHIC FACTOR THERAPY FOR PARKINSON'S DISEASE.RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH. VOL. 184. ISSUE . P. 237 -264 | 134 | 67% | 0 |
6 | REDMOND, DE , (2002) CELLULAR REPLACEMENT THERAPY FOR PARKINSON'S DISEASE - WHERE WE ARE TODAY?.NEUROSCIENTIST. VOL. 8. ISSUE 5. P. 457 -488 | 157 | 66% | 46 |
7 | QUARTU, M , SERRA, MP , BOI, M , FERRETTI, MT , LAI, ML , DEL FIACCO, M , (2007) TISSUE DISTRIBUTION OF RET, GFRALPHA-1, GFRALPHA-2 AND GFRALPHA-3 RECEPTORS IN THE HUMAN BRAINSTEM AT FETAL, NEONATAL AND ADULT AGE.BRAIN RESEARCH. VOL. 1173. ISSUE . P. 36-52 | 101 | 81% | 11 |
8 | REDDINGTON, AE , ROSSER, AE , DUNNETT, SB , (2014) DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO STRIATAL PROJECTION NEURONS: A PURE MSN FATE MAY NOT BE SUFFICIENT.FRONTIERS IN CELLULAR NEUROSCIENCE. VOL. 8. ISSUE . P. - | 91 | 75% | 3 |
9 | MINGUEZ-CASTELLANOS, A , ESCAMILLA-SEVILLA, F , (2005) CELL THERAPY AND OTHER NEUROREGENERATIVE STRATEGIES IN PARKINSON'S DISEASE (I).REVISTA DE NEUROLOGIA. VOL. 41. ISSUE 10. P. 604 -614 | 95 | 90% | 4 |
10 | FREED, WJ , (1991) SUBSTANTIA-NIGRA GRAFTS AND PARKINSONS-DISEASE - FROM ANIMAL-EXPERIMENTS TO HUMAN THERAPEUTIC TRIALS.RESTORATIVE NEUROLOGY AND NEUROSCIENCE. VOL. 3. ISSUE 3. P. 109 -134 | 135 | 93% | 60 |
Classes with closest relation at Level 2 |